Industry News
Cancer immunotherapy 'takes the brakes off natural killer cells'
5/24/2016
Researchers suggest removing a protein that acts as a brake on natural killer cells could boost the immune system's ability to destroy cancer cells.
Men with blood cells that do not carry the Y chromosome are at greater risk of being diagnosed with Alzheimer's disease (AD), and this is in addition to an increased risk of death from other...
Study finds breast and ovarian cancer may have similar origins
5/24/2016
While breast cancer is the most common cause of cancer death in women worldwide, ovarian cancer also is a significant source of mortality as the fifth leading cause of cancer death among women.
Worry about wasting GP's time stopping people from reporting cancer symptoms
5/24/2016
Worrying about wasting their GP's time is stopping people reporting cancer alarm symptoms, according to a Cancer Research UK-funded study published in the British Journal of General Practice.
Novel trial approaches may help to make cancer treatments more precise
5/23/2016
Newer trial designs may help to personalize cancer treatments based on DNA alterations in tumors, rather than on primary tumor site or stage of disease.
A new study indicates that many young adult female cancer survivors do not receive adequate information about their fertility as part of their survivorship care after completing treatment, despite...
Ovarian cancer: Immunotherapy may overcome chemotherapy resistance
5/23/2016
One barrier to successful ovarian cancer treatment is that eventually the cancer becomes resistant to chemotherapy. Researchers suggest immunotherapy may be a way to overcome this.
Continued treatment with nivolumab may improve survival in patients with advanced kidney cancer
5/23/2016
Only 12% of kidney cancer patients with advanced disease survive five years after their initial treatment.
Tiny packages may pack powerful treatment for brain tumors
5/23/2016
Nanocarrier provides efficient delivery of chemotherapeutic drug.Great discoveries do come in small packages. Few know that better than Ann-Marie Broome, Ph.D.
Breaking down cancer cell defenses
5/23/2016
The mistaken activation of certain cell-surface receptors contributes to a variety of human cancers.